Biotech firm says it has identified antibodies to treat COVID-19

Published March 24, 2020 3:48pm

Regeneron Pharmaceuticals Inc said on Tuesday it had identified hundreds of antibodies that could potentially treat the coronavirus

The company said it will select the top two antibodies to develop a “cocktail” treatment and that it plans to begin large-scale manufacturing of the treatment by mid-April.

Regeneron in February announced a partnership with the U.S. Department of Health and Human Services to develop a coronavirus treatment and said it would focus on monoclonal antibodies.

The company is also testing its rheumatoid arthritis drug, Kevzara, with partner Sanofi SA against the virus. -Reuters


Share on facebook
Share on twitter
Share on pinterest
Share on linkedin

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts